Thank you, Mr. Chair.
Thank you to all the witnesses for being here with us and for your great knowledge.
As the chair said, I'm sharing my time with Rob.
My first question is on the funding.
In your study the estimated cost of universal public coverage of prescription drugs in Canada, for establishing a universal drug plan, would reduce government expenses by $2.9 billion in the best-case scenario, or would increase them by $5.4 billion in the worst-case scenario. In order to better understand the large differences between these two possibilities, could you elaborate on the elements that would guide this implementation of the best-case scenario reducing government expenses, and on those that could lead to an increase in costs?